Clinical Trials Logo

Fanconi Syndrome clinical trials

View clinical trials related to Fanconi Syndrome.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT04656171 Withdrawn - Fanconi Anemia Clinical Trials

Microcephaly, Fanconi Anemia and Praxial Disorders

MicroFancII
Start date: January 30, 2023
Phase: N/A
Study type: Interventional

Fanconi Anemia (FA) is mentioned in children with congenital malformations including kidney, hart and skeletal malformations (absence or abnormal thumb or forearm), and bone marrow failure or myelodysplasia with a progressive onset in childhood or adulthood. No study has focused on microcephaly, a reduction in brain volume, which is present in 20% of children, and its consequences on cognitive and structural level of the brain. Since 2014, Robert-Debré's team has been interested in this functional cognitive and neuroanatomical approach trough a National PHRC. Preliminary results carried out on 12 children show that their intellectual efficiency was in the normal range for age. However, we noticed a significant difference between abilities in comprehension and verbal reasoning corresponding to what is expected for age, and the sensorimotor skills or fine motor praxia significantly reduced. These difficulties, graphically penalizing for these children, are not always explained by a skeletal malformation of the upper limb, suggesting that musculo-tendinous anomalies may be associated. The objectives of our project are: 1) to identify upper limb musculo-tendinous abnormalities and their functional consequences, 2) to determine if these abnormalities could influence the somatosensory representation of the upper limb at the cerebral cortical level. This project should help us to better understand the fine motor disabilities or developmental coordination disorder of these children, which penalize their learning, and provide them with adapted solutions.

NCT ID: NCT02837523 Withdrawn - Hypophosphatemia Clinical Trials

Biomarker for Cystinosis Disease: BioCystinosis (BioCystinosis)

BioCystinosis
Start date: August 20, 2018
Phase:
Study type: Observational

Development of a new mass spectrometry-based biomarker for the early and sensitive diagnosis of Cystinosis disease from the blood

NCT ID: NCT02127905 Withdrawn - Fanconi Anemia Clinical Trials

Unrelated HSCT in Patients With Fanconi Anemia

Start date: March 2011
Phase: N/A
Study type: Interventional

The protocol is designed for the compassionate treatment of patients with Fanconi Anemia who do not have an HLA-matched sibling donor. The purpose of this study is to determine the likelihood of engraftment in Fanconi Anemia patients using total body irradiation (TBI), cyclophosphamide (CY), fludarabine (FLU) and antithymocyte globulin (ATG) followed by an unrelated donor hematopoietic cell transplant with T-cell depletion using the CliniMACS device.